- Home
- MX vs PRQR Comparison
MX vs PRQR Comparison
Compare MX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | PRQR |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | South Korea | Netherlands |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.4M | 166.5M |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MX | PRQR |
|---|---|---|
| Price | $4.65 | $1.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.75 | ★ $7.25 |
| AVG Volume (30 Days) | ★ 3.8M | 1.0M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $178,860,000.00 | N/A |
| Revenue This Year | $8.55 | N/A |
| Revenue Next Year | $6.37 | $13.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $1.33 |
| 52 Week High | $9.86 | $3.10 |
Technical Indicators
Market Signals| Indicator | MX | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 40.77 | 46.38 |
| Support Level | $2.64 | $1.39 |
| Resistance Level | $4.76 | $1.70 |
| Average True Range (ATR) | 0.61 | 0.16 |
| MACD | -0.29 | 0.01 |
| Stochastic Oscillator | 4.42 | 30.95 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The Company operates within a single operating segment, Power Solutions business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.